Evidence map›Paper›PMID 42811396›Full record

ReviewThe European journal of neuroscience2026

Rethinking the Oligodendrocyte Progenitor Cell: One Cell, Many Functions.

Alerie G de la Fuente

Abstract readReview
In one paragraph

Review in The European journal of neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alerie G de la FuenteInstituto de Neurociencias CSIC-UMH, Alicante, Spain.ORCID https://orcid.org/0000-0001-8366-4969

Funding

Generalitat Valenciana CIPROM/2022/15Ministerio de Ciencia Innovación y Universidades, Agencia Estatal de Investigación CEX2021-001165-SMinisterio de Ciencia Innovación y Universidades, Agencia Estatal de Investigación PID2024-161979OB-I00
6 · The paper itself

Abstract

Oligodendrocyte progenitor cells (OPCs) are resident progenitors and the largest cycling nonneuronal population of the central nervous system (CNS). For decades, OPCs were defined by a single output-the myelinating oligodendrocyte. However, a growing body of evidence has since revealed a cell whose functions reach well beyond myelin, raising the question of whether the OPC should be regarded as a glial cell type in its own right. In this review I examine a broader repertoire of OPC functions and their relevance to CNS health and disease, alongside myelination, remyelination and myelin maintenance. Beyond forming myelinating oligodendrocytes, OPCs tune myelination to neuronal activity, regulate neural circuits directly, influence the vasculature and blood-brain barrier and act as immune sensors and effectors. These emerging myelin-independent functions establish OPCs as active participants in CNS physiology and pathology rather than a cell defined solely by the oligodendrocytes it produces. Finally, I consider two challenges shared across all these functions and that have, until now, been studied almost exclusively in relation to myelination: OPC heterogeneity and ageing. Whether these noncanonical functions are performed by all OPCs or by distinct subsets and inducible states and how each function is shaped across the lifespan and in pathological contexts, remains unresolved. I propose that addressing these questions is essential to understanding the relevance of these different OPC functions in health and disease.

Indexed as

Myelin SheathOligodendrocyte Precursor CellsOligodendrogliaAnimalsCentral Nervous SystemHumans

Identifiers

PMID42811396
PMCPMC13624055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.